Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function - PubMed (original) (raw)
Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function
I M Rosenberg et al. Am J Physiol. 1997 Oct.
Abstract
Epithelial cell kinase (Eck) is a member of a large family of receptor tyrosine kinases whose functions remain largely unknown. Expression and regulation of Eck and its cognate ligand B61 were analyzed in the human colonic adenocarcinoma cell line Caco-2. Immunocytochemical staining demonstrated coexpression of Eck and B61 in the same cells, suggestive of an autocrine loop. Eck levels were maximal in preconfluent cells. In contrast, B61 levels were barely detectable in preconfluent cells and increased progressively after the cells reached confluence. Caco-2 cells cultured in the presence of added B61 showed a significant reduction in the levels of dipeptidyl peptidase and sucrase-isomaltase mRNA, markers of Caco-2 cell differentiation. Cytokines interleukin-1beta (IL-1beta), basic fibroblast growth factor, IL-2, epidermal growth factor, and transforming growth factor-beta modulated steady-state levels of Eck and B61 mRNA and regulated Eck activation as assessed by tyrosine phosphorylation. Functionally, stimulation of Eck by B61 resulted in increased proliferation, enhanced barrier function, and enhanced restitution of injured epithelial monolayers. These results suggest that the Eck-B61 interaction, a target of regulatory peptides, plays a role in intestinal epithelial cell development, migration, and barrier function, contributing to homeostasis and preservation of continuity of the epithelial barrier.
Similar articles
- Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Easty DJ, Guthrie BA, Maung K, Farr CJ, Lindberg RA, Toso RJ, Herlyn M, Bennett DC. Easty DJ, et al. Cancer Res. 1995 Jun 15;55(12):2528-32. Cancer Res. 1995. PMID: 7780963 - Characterization of B61, the ligand for the Eck receptor protein-tyrosine kinase.
Shao H, Pandey A, O'Shea KS, Seldin M, Dixit VM. Shao H, et al. J Biol Chem. 1995 Mar 10;270(10):5636-41. doi: 10.1074/jbc.270.10.5636. J Biol Chem. 1995. PMID: 7890684 - Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.
Pandey A, Shao H, Marks RM, Polverini PJ, Dixit VM. Pandey A, et al. Science. 1995 Apr 28;268(5210):567-9. doi: 10.1126/science.7536959. Science. 1995. PMID: 7536959 - Healing the epithelium: solving the problem from two sides.
Podolsky DK. Podolsky DK. J Gastroenterol. 1997 Feb;32(1):122-6. doi: 10.1007/BF01213309. J Gastroenterol. 1997. PMID: 9058308 Review. - Peptide growth factors: role in epithelial-lamina propria cell interactions.
Mahida YR, Ciacci C, Podolsky DK. Mahida YR, et al. Ann N Y Acad Sci. 1992;664:148-56. doi: 10.1111/j.1749-6632.1992.tb39757.x. Ann N Y Acad Sci. 1992. PMID: 1456646 Review. No abstract available.
Cited by
- Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide.
El Fakiri M, Regupathy AR, Uhlmann L, Ayada N, Geis NM, Domogalla LC, Lahdenranta J, Blakeman B, Wood F, Meyer PT, Huxley P, Eder M, Mudd GE, Eder AC. El Fakiri M, et al. Theranostics. 2024 Aug 6;14(12):4701-4712. doi: 10.7150/thno.96641. eCollection 2024. Theranostics. 2024. PMID: 39239524 Free PMC article. - EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance.
Chu LY, Huang BL, Huang XC, Peng YH, Xie JJ, Xu YW. Chu LY, et al. World J Gastrointest Oncol. 2022 May 15;14(5):973-988. doi: 10.4251/wjgo.v14.i5.973. World J Gastrointest Oncol. 2022. PMID: 35646281 Free PMC article. Review. - A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers.
Gan HK, Parakh S, Lee FT, Tebbutt NC, Ameratunga M, Lee ST, O'Keefe GJ, Gong SJ, Vanrenen C, Caine J, Giovannetti M, Murone C, Scott FE, Guo N, Burvenich IJG, Paine C, Macri MJ, Kotsuma M, Senaldi G, Venhaus R, Scott AM. Gan HK, et al. Invest New Drugs. 2022 Aug;40(4):747-755. doi: 10.1007/s10637-022-01237-3. Epub 2022 Apr 11. Invest New Drugs. 2022. PMID: 35404015 Clinical Trial. - Cytotoxic effect of Ad-ephrinA1-caspase-3-T on breast cancer cells in vitro.
Huang Y, Zhang B, Li Y, Li Z, Zhang Q, Zhao B. Huang Y, et al. Transl Cancer Res. 2019 Feb;8(1):104-110. doi: 10.21037/tcr.2019.01.07. Transl Cancer Res. 2019. PMID: 35116739 Free PMC article. - Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.
Ferguson HR, Smith MP, Francavilla C. Ferguson HR, et al. Cells. 2021 May 14;10(5):1201. doi: 10.3390/cells10051201. Cells. 2021. PMID: 34068954 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous